AA
Affinity Asset Advisors, LLC disclosed a 9.8% stake in LXEO
Affinity Asset Advisors, LLC reported owning 9.8% of Lexeo Therapeutics, Inc. (LXEO) (8,112,913 shares) in a Schedule 13G filed Nov 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 13, 2026
- Source
- Schedule 13G